AC Immune Ltd (ACIU) Receives New Coverage from Analysts at Leerink Swann
Stock analysts at Leerink Swann started coverage on shares of AC Immune Ltd (NASDAQ:ACIU) in a note issued to investors on Tuesday. The brokerage set an “outperform” rating and a $22.00 price target on the stock. Leerink Swann’s target price suggests a potential upside of 44.83% from the stock’s current price.
Several other brokerages also recently commented on ACIU. Credit Suisse Group AG assumed coverage on AC Immune in a research note on Tuesday. They issued an “outperform” rating and a $18.00 price objective for the company. Jefferies Group assumed coverage on AC Immune in a research note on Tuesday. They issued a “buy” rating and a $25.00 price objective for the company.
AC Immune (NASDAQ:ACIU) traded up 5.27% during mid-day trading on Tuesday, reaching $15.19. The company had a trading volume of 252,219 shares. The company has a market capitalization of $750.33 million and a price-to-earnings ratio of 32.81. The stock has a 50-day moving average of $16.11 and a 200 day moving average of $16.11. AC Immune has a 12-month low of $13.01 and a 12-month high of $19.97.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/18/ac-immune-ltd-aciu-receives-new-coverage-from-analysts-at-leerink-swann-2.html
Receive News & Ratings for AC Immune Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AC Immune Ltd and related companies with MarketBeat.com's FREE daily email newsletter.